Your browser doesn't support javascript.
loading
Selenoprotein M Promotes Hypothalamic Leptin Signaling and Thioredoxin Antioxidant Activity.
Gong, Ting; Hashimoto, Ann C; Sasuclark, Alexandru R; Khadka, Vedbar S; Gurary, Alexandra; Pitts, Matthew W.
Afiliación
  • Gong T; Department of Molecular Biosciences and Bioengineering, University of Hawaii, Honolulu, Hawaii, USA.
  • Hashimoto AC; Department of Cell and Molecular Biology, Medical Microbiolgy, and Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
  • Sasuclark AR; Department of Cell and Molecular Biology, Medical Microbiolgy, and Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
  • Khadka VS; Bioinformatics Core in the Department of Complementary and Integrative Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
  • Gurary A; Department of Tropical Medicine, Medical Microbiolgy, and Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
  • Pitts MW; Department of Cell and Molecular Biology, Medical Microbiolgy, and Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
Antioxid Redox Signal ; 35(10): 775-787, 2021 10 01.
Article en En | MEDLINE | ID: mdl-30648404
ABSTRACT

Aims:

Selenoproteins are an essential class of proteins involved in redox signaling and energy metabolism. However, the functions of many selenoproteins are not clearly established. Selenoprotein M (SELENOM), an endoplasmic reticulum (ER)-resident oxidoreductase bearing structural similarity to thioredoxin (TXN), is among those yet to be fully characterized. This protein is highly expressed in hypothalamic regions involved in leptin signaling and has been previously linked to energy metabolism. Herein, we performed a series of studies using in vivo and in vitro models to probe the specific influence of SELENOM on hypothalamic leptin signaling and assess SELENOM-regulated pathways. Innovation and

Results:

Our initial experiment in vivo demonstrated that (i) leptin promotes hypothalamic expression of SELENOM and (ii) leptin-induced STAT3 phosphorylation is impeded by SELENOM deficiency. Additional in vitro studies using mHypoE-44 immortalized hypothalamic neurons corroborated these findings, as SELENOM deficiency obstructed downstream STAT3 phosphorylation and cytosolic calcium responses evoked by leptin treatment. Correspondingly, SELENOM overexpression enhanced leptin sensitivity. Microarray analysis conducted in parallel on hypothalamic tissue and mHypoE-44 cells revealed multiple genes significantly affected by SELENOM deficiency, including thioredoxin interacting protein, a negative regulator of the TXN system. Further analysis determined that (i) SELENOM itself possesses intrinsic TXN activity and (ii) SELENOM deficiency leads to a reduction in overall TXN activity. Finally, mHypoE-44 cells lacking SELENOM displayed diminished activation of the nuclear factor kappa-light-chain enhancer of activated B-cells (NF-κB) signaling pathway and increased susceptibility to ER stress-mediated cell death.

Conclusion:

In sum, these findings establish SELENOM as a positive regulator of leptin signaling and TXN antioxidant activity in the hypothalamus. Antioxid. Redox Signal. 35, 775-787.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tiorredoxinas / Leptina / Selenoproteínas / Hipotálamo / Antioxidantes Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tiorredoxinas / Leptina / Selenoproteínas / Hipotálamo / Antioxidantes Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article